leishmaniasis

Documents about leishmaniasis

• Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia#1349974ClinicalTrials.gov
• Miltefosine to Treat Mucocutaneous Leishmaniasis#1183238ClinicalTrials.gov
• Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis#908737ClinicalTrials.gov
• Diagnosis and Treatment of Leishmania Infections#1244969ClinicalTrials.gov
• Intralesional Antimony for Bolivian Cutaneous Leishmaniasis#855500ClinicalTrials.gov
• Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis#1060400ClinicalTrials.gov
• Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients#1279995ClinicalTrials.gov
• Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis#1310204ClinicalTrials.gov
• Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis#1086041ClinicalTrials.gov
• Miltefosine for Mucosal Leishmaniasis#881285ClinicalTrials.gov
• Epidemiology of Imported Cutaneous Leishmaniasis: A Narrative Review#676115Europe PMC
• Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry#894905ClinicalTrials.gov
• Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly#888142ClinicalTrials.gov
• Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis#261306ClinicalTrials.gov
• Mediterranean Visceral Leishmaniasis With Leishmania Infantum#1487087ClinicalTrials.gov
• Investigation of Viscerotropism-Associated Genes in Leishmania Tropica Strains Causing Visceral Leishmaniasis#293722İzmir Yüksek Teknoloji Enstitüsü
• The Healthcare Professionals and the Leishmaniasis#1126416ClinicalTrials.gov
• Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis#810397ClinicalTrials.gov
• Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.#883644ClinicalTrials.gov
• Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol#1463953ClinicalTrials.gov
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis#1376413ClinicalTrials.gov
• Use of Sodium Stibogluconate as a Treatment for Leishmaniasis#888279ClinicalTrials.gov
• Low Antimonial Dosage in American Mucosal Leishmaniasis#1421496ClinicalTrials.gov
• The economic impact of Visceral Leishmaniasis in Baringo, Kenya#956209SU+ Digital Repository
• Cutaneous Leishmaniasis Diagnostic Study#1245265ClinicalTrials.gov
• Taxonomy, diversity, temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: A retrospective study#236932Repositorio institucional EdocUR
• Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis#1137945ClinicalTrials.gov
• From visceral to visible: A systematic review and meta-analysis of post-kala-azar dermal leishmaniasis incidence, risk factors, and treatment outcomes in Eastern Africa#465480PLOS
• Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.#853975ClinicalTrials.gov
• Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis#1074457ClinicalTrials.gov
• Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis#851564ClinicalTrials.gov
• Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis#1058603ClinicalTrials.gov
• Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan#915648ClinicalTrials.gov
• Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly#1096180ClinicalTrials.gov
• Performance of RPA-LF for Cutaneous Leishmaniasis#1165001ClinicalTrials.gov
• Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis#1475993ClinicalTrials.gov
• Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396#881295ClinicalTrials.gov
• A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis#860243ClinicalTrials.gov
• Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis#127716ClinicalTrials.gov
• WHO guidelines on leishmaniases: treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis...#410633World Health Organization
• Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients#1163386ClinicalTrials.gov
• Liposomal Amphotericin in Disseminated Leishmaniasis#1438095ClinicalTrials.gov
• Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis#1058968ClinicalTrials.gov
• Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis#1361976ClinicalTrials.gov
• Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)#1087396ClinicalTrials.gov
• Travel history and occupation among diagnosed Cutaneous Leishmaniasis cases in Guyana: A multi-site retrospective case series, 2017–2021#1330563PLOS
• Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World#1046219ClinicalTrials.gov
• Sodium Stibogluconate Treatment of Leishmaniasis#887099ClinicalTrials.gov
• Clinical Prognostic Score to Predict Relapse in VL#1031836ClinicalTrials.gov
• Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers#1088248ClinicalTrials.gov